4.4 Article

Treatment of helicobacter pylori infection using a novel antiadhesion compound (3′sialyllactose sodium salt).: A double blind, placebo-controlled clinical

期刊

HELICOBACTER
卷 8, 期 4, 页码 252-256

出版社

BLACKWELL PUBLISHING INC
DOI: 10.1046/j.1523-5378.2003.00152.x

关键词

Helicobacter pylori infection; antiadhesive therapy; 3 ' sialyllactose sodium salt; C-13-urea breath test

向作者/读者索取更多资源

Background and Aim. 3' sialyllactose sodium salt (3'SL) is an oligosaccharide that occurs naturally in human and bovine milk. It can inhibit the adhesion of H. pylori to human epithelial cells in vitro. The aim of this study was to test whether this oligosaccharide can suppress or cure H. pylori colonization in vivo and to determine its safety in humans. Methods. Seventy-one consecutive dyspeptic patients with H. pylori infection documented by histology and C-13-Urea Breath Test (UBT) were initially recruited to this study. Patients with UBT values < 15 were excluded, thus reducing the enrolment to 65 patients. They were given two different dosages of 3'SL (10 g or 20 g /day) in three daily administrations before meals or placebo for 4 weeks, according to a randomised double-blind protocol. A standardized C-13-UBT (using 100 mg of C-13 labelled urea) was repeated in all patients at fixed intervals during treatment (at the end of weeks 1, 2 and 4) and 4 weeks after treatment withdrawal. Patients compliance and side-effects were evaluated at each weekly visit. Results. Five patients were excluded from the PP analysis due to violation of the protocol (noncompliance, lost to follow-up), whereas 61 patients completed correctly the study: 17 received 3'SL 10 g/day, 22 were treated with 3'SL 20 g/day and 21 were given placebo. The three treatment groups did not significantly differ in demographic or clinical patient characteristics. No serious adverse events were observed during therapy in any of the three groups. No patients became UBT negative (< 4) during or after treatment but UBT values decreased significantly during the study period in both treatment groups and placebo. Conclusions. Antiadhesive therapy was safe and well tolerated but did not suppress or cure H. pylori colonization in humans. The observed decrease in UBT values could be explained by a regression towards the mean effect.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据